Main Article Content


The number of COVID-19 cases, especially with pregnancy, remains a problem in the world and in Indonesia. The main clinical symptoms include fever (temperature >38°C), cough, and shortness of breath. In addition, it can be accompanied by fatigue, myalgia, gastrointestinal symptoms such as diarrhea, and even recently found manifestations of skin disorders. Skin manifestations in COVID-19 pregnant patients are still a rare condition. Skin manifestations can be an early sign of such infection, which therefore requires clinicians’ notice to allow them to conduct early COVID-19 screening in pregnant women for better outcomes of the mother and the baby. We present a 26-year-old primigravida at 39 weeks of gestational age with premature rupture of membranes and COVID-19 infection. Her complaints included itchy maculopapular rash and urticaria, then the pregnancy was terminated by a caesarean section, and the baby was born with good conditions. The skin lesions were given a mixture of corticosteroid cream and fusidic acid. The mother and the baby were discharged in a good condition.


skin manifestations pregnancy COVID-19

Article Details

Author Biographies

Sri Sulistyowati, Department of Obstetrics and Gynecology, Sebelas Maret University Hospital/Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia

Department of Obstetric and Gynecology, Sebelas Maret University Hospital/Faculty of Medicine, Universitas Sebelas Maret, Indonesia

Nutria Widya Purna Anggraini, Department of Obstetrics and Gynecology, Dr. Moewardi Hospital/Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia

Department of Obstetric and Gynecology Dr Moewardi Hospital/Faculty of Medicine, Universitas Sebelas Maret, Indonesia

How to Cite
Sulistyowati, S., & Anggraini, N. W. P. (2021). Skin manifestations of COVID-19 in a pregnant woman with premature rupture of membranes: A case report. JKKI : Jurnal Kedokteran Dan Kesehatan Indonesia, 12(1), 98–104.


  1. Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, et al. Evidence of Coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: A review on neurological impairments and manifestations. Journal of Molecular Neuroscience. 2021;1-18.
  2. WHO. WHO Health Emergency Dashboard.
  3. Pemda Prov Jateng. Jateng tanggap Covid-19. Tanggap Covid-19 provinsi Jawa Tengah. 2020.
  4. Setiati. COVID-19 and Indonesia. Acta Medica Indonesiana.
  5. Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M et al. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology. 2020; 225(6): 152008.
  6. Hantoushzadeh S, Shamshirsaz SA, Ashraf Aleyasin A, Seferovic MD, Aski SK, Arian SE et al. Maternal death due to COVID-19. American Journal of Obstetrics and Gynecology. 2020;223(1):109.e1-16.
  7. Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G. Why are pregnant women susceptible to viral infection: An immunological viewpoint?. Journal of Reproductive Imunology. 2020;139:103122.
  8. Bacenková D, Trebunová M, Špakovská T, Schnitzer M, Bednarcíková L, Živcák J. Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63. Applied Sciences. 2021;11:1497.
  9. Gulcin UC. SARS-CoV-2 during pregnancy and associated cytokine-storm. Critical Care Obstetrics and Gynecology. 2020;6(3):1-3.
  10. Makvandi S, Ashtari S, Vahedian-Azimi A. manifestations of COVID-19 in pregnant women with focus on gastrointestinal symptoms: A systematic review. Gastroenterology and Hepatology from Bed to Bench. 2020;13(4):305–12.
  11. Bian J, Li Z. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharmaceutica Sinica 2021;11(1): 1–12.
  12. Xue X, Mi Z, Wang Z, Pang Z, Liu H, Zhang F. High expression of ACE2 on keratinocytes reveals skin as a potential target for SARS-CoV-2. Journal of Investigative Dermatology. 2021;141(1):206-209.e1.
  13. Sachdeva M, Gianotti R, Shah M, Bradanini L, Tosi D. Veladi S et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. Journal of Dermatological Science. 2020; 98(2): 75–81
  14. Singh H, Kaur H, Singh K, Sen CK. Cutaneous manifestations of COVID-19: A systematic review. Advances in Wound Care. 2021;10(2):51-80.
  15. Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. The American journal of emergency medicine. 2020;38(9):1715-21.
  16. González GF, Cortés CC, Peñaranda CE. Cutaneous manifestations in patients with COVID-19: Clinical characteristics and possible pathophysiologic mechanisms. Actas Dermo-Sifiliograficas. 2020.
  17. Daneshgaran G, Dubin DP, Gould DJ. Cutaneous manifestations of COVID-19: An evidence-based review. American Journal of Clinical Dermatology. 2020;21(5):627–39.
  18. Català A, Galván-Casas C, Carretero-Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa A, et al. Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study. Dermatologic Therapy. 2020;33(6):e14170.
  19. Kaya G, Kaya A, Saurat J-H. Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: Review of the literature. dermatopathology. 2020;7(1):3–16.
  20. Putra BE, Adiarto S, Dewayanti SR, Juzar DA. Viral exanthem with “Spins and needles sensation” on extremities of a COVID-19 patient: A self-reported case from an Indonesian medical frontliner. International Journal of Infectious Diseases. 2020; 96:355–358.
  21. Abuelgasim E, Dona ACM, Sondh RS, Harky A. Management of urticaria in COVID-19 patients: A systematic review. Dermatologic Therapy. 2021;34:e14328.
  22. Wollina U, Karadag AS, Rowland-Payne C, Chiriac A, Lotti T. Cutaneous signs in COVID-19 patients: A review. Dermatologic Therapy. 2020;33:e13549.
  23. Ring J. The skin in the era of coronavirus pandemic. Journal of the European Academy of Dermatology and Venereology. 2020; 34:1384–1385.
  24. Novak N, Peng W, Naegeli MC, Galvan C, Kolm-Djamei I, Brüggen C, et al. SARS-CoV-2, COVID-19, skin and immunology–what do we know so far? Allergy. 2021;76:698-713.
  25. Türsen U, Belma Türsen B , Torello Lotti T. Cutaneous side-effects of the potential COVID-19 drugs. Dermatologic Therapy. 2020: e13476.
  26. Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, Catherine Y. Spong CY. Williams Obstetrics, 25e. Chapter42. America: McGraw-Hill Medical, 2018.
  27. Pérez OM, Rodriguez PP, Hernandez MM, Pardilla MBE, Perez Perez N, Hernandez MRV, et al. The association between COVID-19 and preterm delivery: A cohort study with a multivariate analysis. medRxiv. 2020.
  28. Radam MR, Soetrisno S, Respati SH. Heat Shock Protein 70 (Hsp70) level is lower in premature rupture of membrane. Indonesian Journal of Obstetrics and Gynecology. 2014;2(2):69–75.